Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT04415853

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

This is a randomized, controlled, multi-center, open trial, unresectable locally advanced or metastatic esophageal squamous cell carcinoma patients that failed…

China416 participantsStarted 2021-01-21

Treatment: Lerotinib, Irinotecan/Tegafur

All recent trials (11 shown)

Not Yet RecruitingPhase 2/3

NCT07554456

A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizuma…

This trial is a registrational Phase II/III, randomized, controlled, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in combinatio…

China90 participantsStarted 2026-04

Treatment: BL-B01D1, Tislelizumab

CompletedPhase 3

NCT04540211

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cispl…

The purpose of this study is to evaluate the efficacy and safety of atezolizumab plus tiragolumab in combination with paclitaxel and cisplatin (PC) compared wit…

China461 participantsStarted 2020-10-30

Treatment: Atezolizumab, Tiragolumab

Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

All recent trials (11 shown)

A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizuma…

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cispl…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

All recent trials (11 shown)

A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizuma…

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cispl…

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in P…

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advance…

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlima…

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected…

A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurr…

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors